Patrick Heron
Chairman bij ARCUTIS BIOTHERAPEUTICS, INC.
Vermogen: 516 570 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Patrick Heron
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.
163
| Private Company | Miscellaneous Commercial Services | 163 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington.
143
| Subsidiary | Investment Managers | 143 |
The University of North Carolina at Chapel Hill
117
| College/University | Other Consumer Services | 117 |
Harvard Business School
54
| College/University | Other Consumer Services | 54 |
| Public Company | Pharmaceuticals: Major | 45 | |
| Public Company | Pharmaceuticals: Major | 25 | |
| Public Company | Biotechnology | 20 | |
| Public Company | Pharmaceuticals: Major | 20 | |
| Public Company | Pharmaceuticals: Major | 19 | |
| Public Company | Biotechnology | 19 | |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA.
17
| Subsidiary | Pharmaceuticals: Major | 17 |
| Public Company | Biotechnology | 15 | |
| Subsidiary | Pharmaceuticals: Major | 14 | |
MedPointe, Inc.
 MedPointe, Inc. Pharmaceuticals: MajorHealth Technology MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
QuatRx Pharmaceuticals Co.
 QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
| Public Company | Pharmaceuticals: Other | 11 | |
| Subsidiary | Biotechnology | 10 | |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Iterum Therapeutics US Holding Ltd.
 Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Iterum Therapeutics US Holding Ltd. operates as a clinical-stage pharmaceutical company. The company was founded in 2018 and is headquartered in Chicago, IL.
8
| Subsidiary | Financial Conglomerates | 8 |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN.
8
| Holding Company | Electronic Equipment/Instruments | 8 |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Scout Bio, Inc.
 Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
VentiRx Pharmaceuticals, Inc.
 VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Marcadia Biotech, Inc.
 Marcadia Biotech, Inc. Pharmaceuticals: MajorHealth Technology Marcadia Biotech, Inc. develops therapeutic products for diabetes and obesity. It is a biopharmaceutical company focuses on developing a broad portfolio of drug candidates for treatment of diabetes and obesity. The company was founded in 2005 and is headquartered in Carmel, IN.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Calibrium LLC
 Calibrium LLC Pharmaceuticals: MajorHealth Technology Calibrium LLC develops biopharmaceuticals and diabetic drugs. The company is a biotech company that develops novel peptides that helps in the treatment of diabetes and related metabolic diseases. The company was founded by Fritz French and Richard DiMarch in 2013 and is headquartered in Carmel, IN.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Amunix, Inc.
 Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA.
5
| Private Company | Pharmaceuticals: Major | 5 |
Calixa Therapeutics, Inc.
 Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Calixa Therapeutics, Inc. develops and commercializes hospital-based anti-infective therapies. The company was founded by Eckard Weber and James Ge in 2007 and is headquartered in San Diego, CA.
4
| Extinct | Pharmaceuticals: Major | 4 |
Zavante Therapeutics, Inc.
 Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zavante Therapeutics, Inc. manufactures pharmaceutical products. Its product ZOLYD is an investigational, first-in-class epoxide antibiotic with a spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. The company was founded by Cam L. Garner, Evelyn Ellis-Grosse and Theodore R. Schroeder in 2013 and is headquartered in San Diego, CA.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Silvergate Pharmaceuticals, Inc.
 Silvergate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silvergate Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It specializes in reformulating adult drugs and supplies it to the pediatric market. The company was founded by Frank Segrave in 2010 and is headquartered in Greenwood Village, CO.
1
| Extinct | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Patrick Heron via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal Investor Relations Contact | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Director/Board Member | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Corporate Officer/Principal General Counsel Chief Executive Officer Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Founder President Corporate Officer/Principal Corporate Officer/Principal | |
| ANAPTYSBIO, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Chairman Chief Executive Officer | |
| SI-BONE, INC. | Medical Specialties | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Corporate Secretary | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| Stanford University | College/University | Corporate Officer/Principal Doctorate Degree Masters Business Admin Corporate Officer/Principal Graduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Masters Business Admin | |
| University of Pennsylvania | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
| University of California, Los Angeles | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| Indiana University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| Middlebury College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Director/Board Member | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Graduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Graduate Degree Masters Business Admin | |
Ziarco Group Ltd.
 Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Ziarco Group Ltd. operates as a clinical-stage biotechnology company that develops therapeutics targeting inflammatory skin diseases. The firm engages in development of novel treatments in dermatology. The company was incorporated on March 10, 2014 and is headquartered in Canterbury, the United Kingdom. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member Founder Director/Board Member | |
Cirius Therapeutics, Inc.
 Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
| ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| SPRUCE BIOSCIENCES, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer | |
| PHATHOM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Chief Executive Officer Founder | |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Founder | |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Information Technology ServicesTechnology Services Sudo Biosciences, Inc. is a biopharmaceutical company that focuses on designing and developing innovative medicines to improve the lives of patients. Sudo Biosciences is based in Menlo Park, CA, and has operations in other locations. The company's primary focus is on developing treatments that target the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a crucial mediator in cytokine signaling pathways that have been associated with various immune-mediated inflammatory conditions. The CEO of the company is Scott A. Byrd. | Information Technology Services | Director/Board Member Director/Board Member Director/Board Member | |
| DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member President Corporate Secretary Director of Finance/CFO President Chief Tech/Sci/R&D Officer Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 47 |
| Ierland | 3 |
| Verenigd Koninkrijk | 3 |
Sectoraal
| Health Technology | 35 |
| Consumer Services | 12 |
| Commercial Services | 3 |
| Finance | 3 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 871 |
| Independent Dir/Board Member | 280 |
| Corporate Officer/Principal | 258 |
| Chairman | 127 |
| Chief Executive Officer | 112 |
Sterkste connecties
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Steven Gillis | 58 |
| James Healy | 50 |
| James Topper | 49 |
| Ed Mathers Mathers | 47 |
| Eckard Weber | 46 |
| Heath Lukatch | 43 |
| Stephen P. Squinto | 40 |
| Timothy Walbert | 40 |
| Peter Thompson | 39 |
| John Freund | 37 |
| Ambrose Bailey | 32 |
| Michael Grey | 32 |
| Shelley Chu | 31 |
| Alan Frazier | 31 |
- Beurs
- Insiders
- Patrick Heron
- Bedrijfsconnecties
